查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1470996

热原测试市场：按产品类型、测试类型、最终用户划分 - 2024-2030 年全球预测

Pyrogen Testing Market by Product Type (Assays, Kits, & Reagents, Instruments, Services), Test Type (Limulus Amoebocyte Lysate, Monocyte Activation Test, Rabbit Tests), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

热原测试市场规模预计2023年为12.4亿美元，2024年达到13.8亿美元，预计2030年将达到26.8亿美元，复合年增长率为11.64%。

热原测试是生物技术、医疗设备和製药业采用的重要程序，用于确保注射药物、医疗设备和其他与人体直接接触的产品的安全和品质。热原是一种当摄入人体时会引起发烧的物质，即使是少量。这些物质包括细菌内毒素（其主要是革兰氏阴性细菌细胞壁的成分），以及其他引起发热反应的微生物和非微生物污染物。人们对药品安全性和有效性的认识和警觉性不断提高，导致人们更加关注包括热原在内的污染物检测。此外，世界各地卫生当局製定的严格法规和标准要求进行全面的热原测试，这增加了对测试服务和产品的需求。然而，先进的热原测试方法的成本很高并且可能令人望而却步，特别是对于中小企业（SME）而言。此外，日益转向非动物测试方法为合成和重组热原测试的创新提供了重大机会。

主要市场统计
基准年[2023] 12.4亿美元
预测年份 [2024] 13.8亿美元
预测年份 [2030] 26.8亿美元
复合年增长率（%） 11.64%

产品类型：对自动化、加速和增强测试过程的检测、套件和试剂的需求增加

测定、套件和试剂专为特定测试技术而设计，例如鲎变形细胞裂解物 (LAL) 测试、单核细胞活化测试 (MAT) 测试和兔热原测试 (RPT) 测试。这些产品提供检测热原的存在和浓度所需的生化和生物成分。热原测试涉及的设备包括用于自动化、促进和增强测试过程的装置和设备。此部分包括内毒素检测系统、培养箱和光强度等专用设备。设备范围从基本测试设备到支援高通量测试、提高灵敏度并确保准确性的先进自动化系统。热原检测服务涵盖专业实验室和公司提供的服务。这些服务范围从端到端热原测试到研究设计和法规遵循咨询。该服务适用于由于测试复杂性、需要专业知识或实验室能力限製而外包热原测试的组织。

最终用户：生技公司对热原测试的需求增加

生物技术公司处于开发治疗和诊断解决方案的前沿，通常采用新型生物药品。在这些情况下，热原测试可确保这些生物製药不含会引起发烧的污染物。这些公司最担心的是重组蛋白、疫苗和细胞治疗药物可能受到污染，导致患者发烧反应。这些公司倾向于青睐创新、灵敏的测试，例如单核细胞活化测试 (MAT)，该测试可检测传统细菌内毒素以外更广泛的热原。医疗设备公司将热原测试作为产品安全评估的重要组成部分。与人体直接接触的设备，特别是那些用于血管内或鞘内使用的设备，如果受到污染，就有引起发烧反应的风险。这些公司面临的主要挑战是确保从简单的手术器械到复杂的植入的各种器械的无菌性和无热原性。生产各种药品（包括肠外输液）的製药公司必须确保其产品无热原，以防止对患者产生副作用。由于生产的药品数量庞大且种类繁多，该行业是热原测试服务最广泛的用户。

区域洞察

美洲，特别是美国和加拿大，是热原测试的重要市场。美洲市场得益于先进的医疗基础设施、严格的监管政策以及大型製药和生物技术公司的存在。美国因其强大的研究生态系统而脱颖而出，可带来创新的测试解决方案。该市场受到 FDA 法规的支持，这些法规要求对所有註射和植入式医疗设备进行严格的热原测试。欧盟国家在监管标准和市场规模方面处于领先地位，采用欧洲药典标准，强调透过严格的热原测试确保产品安全。庞大的製药工业基地和人们对产品安全意识的提高推动了热原测试的需求。中东和非洲是具有成长潜力的新兴市场。随着医疗保健基础设施和药品生产能力的扩大，人们对热原测试的兴趣与日俱增。由于中国、日本和印度等国家製药业的扩张，亚太地区的热原测试市场正在快速成长。该地区对医疗保健和研究的投资不断增加，重点是品管和安全标准。

FPNV定位矩阵

FPNV定位矩阵对于评估热原测试市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对热原测试市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.热原测试市场的市场规模和预测是多少？

2.热原测试市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3.热原测试市场的技术趋势和法规结构是什么？

4.热原测试市场主要厂商的市场占有率为何？

5.进入热原检测市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病和慢性病发生率增加
      • 增加药品、生技药品和医疗设备产品的产量
      • 世界各地卫生当局製定的严格法规和标准
    • 抑制因素
      • 与先进的热原测试方法相关的高成本
    • 机会
      • 製药和生技公司增加对研发活动的投资
      • 生物技术和热原测试技术的技术进步
    • 任务
      • 与热原测试相关的操作和道德问题
  • 市场区隔分析
    • 产品类型：对自动化、加速和增强测试过程的检测、套件和试剂的需求不断增长
    • 最终用户：生技公司对热原测试的需求增加
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章热原测试市场：依产品类型

  • 测定、套件和试剂
  • 装置
  • 服务

第七章按测试类型分類的热原测试市场

  • 鲎变形虫裂解物
  • 单核细胞活化试验
  • 兔子测试
  • 重组连锁试剂
  • 重组因子C

第八章热原测试市场：依最终用户分类

  • 生技公司
  • 医疗设备公司
  • 製药公司

第九章 北美和南美热原测试市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太热原测试市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲热原检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Charles River Laboratories 推出 Endsafe Trillium rCR 试剂盒，用于高效、非动物测试
    • Lonza 推出先进的快速 MAT 系统
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-035AB9C0DA61

[197 Pages Report] The Pyrogen Testing Market size was estimated at USD 1.24 billion in 2023 and expected to reach USD 1.38 billion in 2024, at a CAGR 11.64% to reach USD 2.68 billion by 2030.

Pyrogen testing is a critical procedure employed in the biotechnology, medical device, and pharmaceutical industries to ensure the safety and quality of injectable pharmaceuticals, medical devices, and other products that come in direct contact with the human body. Pyrogens are substances that, even in small amounts, can induce fever when introduced into the human body. These substances primarily include bacterial endotoxins, which are constituents of Gram-negative bacteria cell walls, and other microbial and non-microbial contaminants that elicit a pyrogenic response. Increased awareness and vigilance regarding drug safety and efficacy have heightened the focus on contaminant testing, including pyrogens. Moreover, stringent regulations and standards set by health authorities worldwide necessitate comprehensive pyrogen testing, fuelling demand for testing services and products. However, the high cost of advanced pyrogen testing methods can be prohibitive, especially for small and medium-sized enterprises (SMEs). Furthermore, the growing shift towards animal-free testing methods presents significant opportunities for innovation in synthetic and recombinant pyrogen testing methods.

KEY MARKET STATISTICS
Base Year [2023] USD 1.24 billion
Estimated Year [2024] USD 1.38 billion
Forecast Year [2030] USD 2.68 billion
CAGR (%) 11.64%

Product Type: Increasing demand of assays, kits, & reagents to automate, facilitate, or enhance the testing processes

Assays, kits, and reagents are designed for specific testing methodologies, such as the Limulus Amebocyte Lysate (LAL) test, Monocyte Activation Test (MAT), and Rabbit Pyrogen Test (RPT), among others. These products provide the biochemical and biological components necessary for detecting the presence and concentration of pyrogens. Instrumentation in pyrogen testing encompasses the devices and equipment used to automate, facilitate, or enhance the testing processes. This segment includes endotoxin detection systems, incubators, and spectrophotometers, among other specialized apparatuses. Instruments range from basic laboratory equipment to sophisticated automated systems that handle high-throughput testing, enhance sensitivity, and ensure precision. The pyrogen testing services cover the offerings provided by specialized laboratories and companies. These services range from end-to-end pyrogen testing to consultation on test design and regulatory compliance. Services cater to organizations that outsource pyrogen testing due to the high complexity of tests, the need for specialized expertise, or constraints in laboratory capacity.

End-User: Increasing demand of pyrogen testing across biotechnology companies

Biotechnology companies are at the forefront of developing therapeutic and diagnostic solutions, often employing novel biological agents. In this context, pyrogen testing ensures these biological products are free from fever-inducing contaminants. The primary concern for these companies is the potential contamination of recombinant proteins, vaccines, and cell therapies, which can provoke pyrogenic responses in patients. These entities tend to prefer innovative, sensitive testing methods such as the Monocyte Activation Test (MAT), which detect a broader range of pyrogens beyond the traditional bacterial endotoxins. Medical device companies incorporate pyrogen testing as a pivotal part of product safety assessments. Devices that come into direct contact with the human body, especially those intended for intravascular or intrathecal use, risk causing pyrogenic reactions if contaminated. The primary challenge for these companies is ensuring the sterility and non-pyrogenicity of a vast array of devices, from simple surgical instruments to complex implants. Pharmaceutical companies producing a wide range of medicinal products, including parenteral solutions, must ensure their products are pyrogen-free to prevent adverse patient reactions. This sector is the most extensive user of pyrogen testing services, given the vast quantities and varieties of drugs produced.

Regional Insights

The Americas, particularly the United States and Canada, represent a substantial market for pyrogen testing. The Americas market is attributed to the advanced healthcare infrastructure, strict regulatory policies, and the presence of key pharmaceutical and biotechnology companies. The United States stands out with its robust research ecosystem, leading to innovative testing solutions. The market is buoyed by FDA regulations that mandate rigorous pyrogen testing for all injectable and implantable medical devices. The EU countries are leading in regulatory standards and market size with the adoption of the European Pharmacopoeia standards, which underscores the commitment to ensuring product safety through rigorous pyrogen testing. The demand for pyrogen testing is driven by a large pharmaceutical industry base and heightened awareness regarding product safety. The Middle East and Africa present a nascent market with growing potential. The interest in pyrogen testing is increasing with the expansion of healthcare infrastructure and pharmaceutical manufacturing capabilities. The Asia Pacific region is witnessing rapid growth in the pyrogen testing market driven by expanding pharmaceutical industries in countries including China, Japan, and India. The region benefits from increasing investments in healthcare and research, coupled with a heightened focus on quality control and safety standards.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pyrogen Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pyrogen Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pyrogen Testing Market, highlighting leading vendors and their innovative profiles. These include Accugen Laboratories, Inc., Associates of Cape Cod, Inc., bioMerieux SA, Charles River Laboratories International, Inc., Corning Incorporated, Ellab A/S by Novo Nordisk A/S, Eurofins Scientific SE, FUJIFILM Corporation, GenScript Biotech Corporation, Indoor Biotechnologies, Inc., Lonza Group, MAT BioTech BV, Merck KGaA, Microcoat Biotechnologie GmbH, Minerva Analytix GmbH by Dilarus GmbH, Nelson Laboratories, LLC by Sotera Health, North American Science Associates, LLC, Pacific BioLabs, Solvias AG, Steris PLC, Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Pyrogen Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Assays, Kits, & Reagents
    • Instruments
    • Services
  • Test Type
    • Limulus Amoebocyte Lysate
      • Chromogenic Tests
      • Gel Clot Tests
      • Turbidimetric Tests
    • Monocyte Activation Test
    • Rabbit Tests
    • Recombinant Cascade Reagent
    • Recombinant Factor C
  • End-User
    • Biotechnology Companies
    • Medical Device Companies
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Pyrogen Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pyrogen Testing Market?

3. What are the technology trends and regulatory frameworks in the Pyrogen Testing Market?

4. What is the market share of the leading vendors in the Pyrogen Testing Market?

5. Which modes and strategic moves are suitable for entering the Pyrogen Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of infectious diseases and chronic diseases
      • 5.1.1.2. Increasing production of pharmaceuticals, biologics, and medical devices products
      • 5.1.1.3. Stringent regulations and standards set by health authorities worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the advanced pyrogen testing methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments in R&D activities by pharmaceutical and biotechnology companies
      • 5.1.3.2. Technological advancements in biotechnology and pyrogen testing technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Operational and ethical concerns associated with the pyrogen testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Increasing demand of assays, kits, & reagents to automate, facilitate, or enhance the testing processes
    • 5.2.2. End-User: Increasing demand of pyrogen testing across biotechnology companies
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Pyrogen Testing Market, by Product Type

  • 6.1. Introduction
  • 6.2. Assays, Kits, & Reagents
  • 6.3. Instruments
  • 6.4. Services

7. Pyrogen Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Limulus Amoebocyte Lysate
  • 7.3. Monocyte Activation Test
  • 7.4. Rabbit Tests
  • 7.5. Recombinant Cascade Reagent
  • 7.6. Recombinant Factor C

8. Pyrogen Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Biotechnology Companies
  • 8.3. Medical Device Companies
  • 8.4. Pharmaceutical Companies

9. Americas Pyrogen Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pyrogen Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pyrogen Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Charles River Laboratories Launches Endosafe Trillium rCR Cartridge for Efficient, Animal-Free Testing
    • 12.3.2. Lonza Introduces Advanced Rapid MAT Systems
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. PYROGEN TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. PYROGEN TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PYROGEN TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PYROGEN TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL PYROGEN TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL PYROGEN TESTING MARKET SIZE, BY RABBIT TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL PYROGEN TESTING MARKET SIZE, BY RABBIT TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT CASCADE REAGENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT CASCADE REAGENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL PYROGEN TESTING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL PYROGEN TESTING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. MEXICO PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. MEXICO PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 110. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. CHINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. CHINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. CHINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 118. CHINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. INDIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. INDIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. INDIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 126. INDIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. INDONESIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. INDONESIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. INDONESIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 134. INDONESIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. JAPAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. JAPAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. JAPAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 142. JAPAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. MALAYSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. MALAYSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. MALAYSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 150. MALAYSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 158. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. SINGAPORE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. SINGAPORE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. SINGAPORE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 166. SINGAPORE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 174. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. TAIWAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. TAIWAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. TAIWAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 182. TAIWAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. THAILAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. THAILAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. THAILAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 190. THAILAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. VIETNAM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. VIETNAM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. VIETNAM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 198. VIETNAM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. DENMARK PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. DENMARK PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. DENMARK PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 216. DENMARK PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. EGYPT PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. EGYPT PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. EGYPT PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 224. EGYPT PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. FINLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. FINLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. FINLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 232. FINLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. FRANCE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. FRANCE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. FRANCE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 240. FRANCE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. GERMANY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. GERMANY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. GERMANY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 248. GERMANY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. ISRAEL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. ISRAEL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. ISRAEL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 256. ISRAEL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. ITALY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. ITALY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. ITALY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 264. ITALY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 272. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. NIGERIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. NIGERIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. NIGERIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 280. NIGERIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. NORWAY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. NORWAY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. NORWAY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 288. NORWAY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. POLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. POLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. POLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 296. POLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. QATAR PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. QATAR PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. QATAR PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. QATAR PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. QATAR PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 304. QATAR PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 305. QATAR PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. QATAR PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. RUSSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. RUSSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. RUSSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. RUSSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. RUSSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 312. RUSSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 313. RUSSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 314. RUSSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 316. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 320. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 328. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 331. SPAIN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 332. SPAIN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 333. SPAIN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 334. SPAIN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 335. SPAIN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 336. SPAIN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 337. SPAIN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. SPAIN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. SWEDEN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. SWEDEN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. SWEDEN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 342. SWEDEN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 343. SWEDEN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 344. SWEDEN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 345. SWEDEN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 346. SWEDEN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 348. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 352. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 354. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 355. TURKEY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 356. TURKEY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE